News

AddToAny

Google+ Facebook Twitter Twitter

SARS-COV-2 spike mutations and infectivity

Researchers at the Francis Crick Institute have compared the original SARS-CoV-2 spike protein with a mutated version that arose last spring. 

They have found structural differences that could help to explain why the mutated version remains the dominant form circulating in all recent variants of concern, such as the UK and South African strains. 

As SARS-CoV-2 has evolved, mutations impacting the structure of the viral spike protein have affected how it binds to and infects cells. 

These changes have had huge implications for the spread of disease as new variants dominate, in part due to changes in the fitness of the virus. 

The scientists used electron cryomicroscopy to gain detailed images of a variant form of SARS-CoV-2 spike protein. They then compared this with a previous study examining the original “Wuhan” form of the virus. The variant spike, called G614, is a mutated version that first arose around spring 2020 and is now the dominant version of the spike in circulation, including in the recently identified variants of concern.

By analysing their structures, the researchers found that the mutated G614 spike would more easily bind to human cells due to its open and flexible structure. While the original spike adopted a generally more closed form, they observed that the mutant spike could adopt a greater number of open and erect conformations, which would prime the protein for binding to the human cell receptor ACE2.

bit.ly/2O1mG5U

 

 

Related Articles

Medical Science Laboratory with Diverse Multi-Ethnic Team of Microbiology Scientists Have Meeting on Developing Drugs, Medicine, Doing Biotechnology Research-CREDIT_istock-1293772951

Equity, diversity and inclusion for all

Jemma Shead, a Senior Biomedical Scientist at Synnovis and IBMS EDI Working Group member, on how and why you should get involved with EDI.

adeno associated virus capsid-Image Credit | Science Photo Library - c0142837

Examining the medical mystery of child hepatitis outbreak

A study has shed light on an unexpected wave of severe acute hepatitis cases in 2022, amid the backdrop of the ongoing global COVID-19 pandemic.

clostridioides difficile bacteria-Image Credit | Science Photo Library - c0016337

Faecal microbiota transplant for C. diff

In the first comprehensive US evidence-based guideline on the use of faecal microbiota-based therapies for gastrointestinal disease, the American Gastroenterological Association recommends faecal microbiota transplant (FMT) for most patients with recurrent Clostridioides difficile (C. diff) infection.

pseudomonas aeruginosa bacteria Image-Credit | Science Photo Library - f0381226

Tackling priority pathogen with phages

A new study describes the use of phage therapy to eradicate multidrug-resistant Pseudomonas aeruginosa infections in vivo with important new implications for antibiotic resistance.

Top